F-star Therapeutics Overview

F-star Therapeutics Gross Profit

Gross Profit analysis for FSTX.

Quarterly Gross Profit

$1.13M

↑ 49.8% YoY

As of Sep 30, 2022

Annual Gross Profit (TTM)

$21.18M

↑ 452.73% YoY

Trailing 12 months ending Sep 30, 2022

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin